top of page

Nazata Bio

AI digital therapy improving hypertension outcomes.

Lifesciences & Healthtech

Furthr 2025 Cohort - PSSF

Founder(s)

Tom McCarton

CEO

Shane O'Neil

CTO

About

A personalised digital therapeutic for hypertension that uses behavioural science and AI-driven insights to improve adherence to lifestyle changes, helping patients lower blood pressure through tailored diet and exercise interventions while extending the reach of clinical care through an accessible mobile platform.

bottom of page